Short answer
Wendy's Co (WEN) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Adoption of one-year poison pill, expiring November 3, 2027, following Trian-led $7.35-per-share unsolicited proposal.
Wendy's Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Adoption of one-year poison pill, expiring November 3, 2027, following Trian-led $7.35-per-share unsolicited proposal
- 15% ownership threshold, including certain derivatives, triggers substantial dilution for an unapproved acquirer
- Rights issued for each common share, with $37.00 exercise price for one one-thousandth of preferred share
- Trian-affiliated directors excluded from approval, highlighting direct conflict between incumbent Board and proposing shareholder group
- Mechanism raises takeover barriers and gives independent directors time to negotiate, reject, or seek superior alternatives
Item 3.03 · Material Modification to Rights of Security Holders
- Item 3.03 links security-holder rights changes to Item 1.01’s material agreement disclosure
- Investor impact depends on the agreement terms described in Item 1.01, not provided here
Item 5.02 · Departure/Election of Directors or Officers
- Change-in-control protections expanded, removing exclusions for transactions involving Nelson Peltz or Peter W. May
- Performance units convert to restricted stock units using actual, target, or relative TSR performance outcomes
- 18-month post-change-in-control protection period for qualifying terminations
- Good Reason resignations treated like company-initiated terminations for severance and equity vesting
- Enhanced executive payout obligations could increase acquisition costs and shareholder dilution risk
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- New Series A preferred stock designation supporting Wendy’s shareholder rights plan
- Certificate establishes rights, powers and preferences for preferred shares
- Delaware filing scheduled for November 5, 2026
- Rights-plan structure may affect takeover prospects and shareholder voting dynamics
Item 7.01 · Regulation FD Disclosure
- Wendy’s rejected an unsolicited, non-binding Investor Group proposal to buy remaining shares for $7.35 per share cash
- Board adopted a Rights Agreement and declared a dividend of shareholder rights, creating a takeover-defense mechanism
- Proposal rejection preserves standalone strategy but leaves potential acquisition uncertainty for shareholders
Item EX-99.1 · Exhibit EX-99.1
- Independent Committee rejected Trian-led $7.35-per-share cash proposal, citing substantial undervaluation of Wendy’s standalone prospects
- Committee backing Dave’s Way strategy, targeting customer traffic, market share and restaurant profitability under CEO Bob Wright
- One-year shareholder rights plan effective immediately, expiring November 3, 2027
- Rights trigger at 15% ownership without Board or Committee approval, limiting potential takeover accumulation without a premium
- Investor Group’s refusal to sign a standstill agreement contributed to adoption of the rights plan
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Wendy's Co 8-K filings
Get the next WEN 8-K as it lands
Follow WEN for push alerts, or ask the research agent what this filing means.